A reduced-pressure treatment system for applying reduced pressure to a tissue site at a limited-access location on a patient includes a reduced-pressure source, a treatment manifold for placing proximate the tissue site and operable to distribute reduced pressure to the tissue site, and a sealing member for placing over the tissue site and operable to form a pneumatic seal over the tissue site. The reduced-pressure treatment system also includes a reduced-pressure bridge and a moisture-removing device on at least portion of the reduced-pressure bridge. The reduced pressure bridge includes a delivery manifold operable to transfer the reduced pressure to the treatment manifold, an encapsulating envelope at least partially enclosing the delivery manifold and having a patient-facing side, and a reduced-pressure-interface site formed proximate one end of the reduced-pressure bridge.

A microneedle set including a microneedle injection device that introduces a liquid to a skin of a body part, and a piercing assisting tool fixable to the body part. The microneedle injection device includes a hollow needle shaped body having a projection in an end portion thereof and a through hole connected to the projection such that the liquid passes through the through hole and is released from a tip portion of the projection, and a supply device that supplies the liquid to the hollow needle shaped body. The piercing assisting tool includes a fixing part which has an aperture formed therein and fixes a position of the aperture on the body part, and a cover connected to a peripheral portion of the aperture such that the aperture is opened or closed by the cover.

Wearable auto-injector devices, systems and methods prevent medication administration in a device-worn state using a mechanism that prevents administration medication or by making it impossible or operationally impractical to physical orient or align the device to achieve injection. The device includes a housing, an attachment component enabling the housing to be worn by a user, and a medication delivery system including a needle and a medication reservoir. An advancement system advances the needle into a user's skin and causes the medication to flow through the needle. Various advancement systems, error-reduction mechanisms, attachment alternatives, and optional monitoring and communications capabilities are disclosed.

Devices and methods can be used to apply an adhesion promoter, for example, ozone, over the surface of the biological tissues, before and/or concurrently with the application of the cosmetics to improve the durability and/or appearance of the cosmetics on the biological tissues. The devices can include a recirculation system and/or a filter system to reduce the likelihood of the chemical being released into the atmosphere and/or to increase oxidation of the chemical generated by the device after use of the device.

An apparatus for applying negative pressure to a tissue site proximate a patient's foot may include a tissue interface, a sole, a toe box, a cover, and an interface. The tissue interface may be configured to be circumferentially disposed around the tissue site. The sole may be configured to support the tissue interface. The toe box may be coupled to the sole. The cover may be configured to be coupled to the leg and to the sole to cover the tissue interface. The cover and the sole may form a chamber containing the tissue interface and may seal the tissue interface within the chamber. The interface may be configured to fluidly couple the tissue interface to a source of negative pressure, which can be delivered to the tissue interface for distribution to the tissue site.

An extremity irrigation debridement basin includes a body having a floor and a sidewall extending between the floor and an upper rim. An opening is positioned opposite the floor and defined by the upper rim. A shield extends upward from the upper rim of the sidewall. A recess is formed in the sidewall. The recess extends from an upper rim opening toward the floor.

A radioisotope elution system is provided. The radioisotope elution system may comprise a controller that is configured to calculate the available amount of daughter radioisotope at any time during establishment of the equilibrium for decay of the parent radioisotope into its daughter radioisotope. The radioisotope elution system may comprise a controller that is configured to schedule various patient infusions planned for the next following days and weeks in accordance with the available amount of daughter radioisotope on each day. The elution system may also comprise a controller that is connected to the imaging software of a radioisotope imaging device, where the radioisotope imaging device is arranged for imaging the patient or a region of the patient; and the controller is configured to start an image acquisition at a predetermined time.

The new invention foot-care equipment unit is directly related to foot problems and cures from pain, numbness, stiffness, swelling, athlete's foot, blisters, bunios, corns, plantar fasciitis, heel spur, mallet or hammer toe, gout, ingrown toenail, nail hardening, fungal nail infection, plantar wart, stone bruise, morton neuroma, sesamoidits, poor blood circulation, crack heals, blood clots in the foot vain or excessive sweat, and or bad odours are common symptom of foot related issues or causes of poor foot health. The foot-care equipment a hands free solution for practicing random or regularly use of equipment for steaming, fermenting, massaging, cleaning and sanitizing, air blow drying, sterilizing and or scrubbing of foot or the feet's for cure or general health and hygiene as therapy or treatment. The foot-care equipment unit may comprise of semi-automatically functional in cleaning, sanitizing and sterilizing, and or drying of its equipment components for users.

A blood flow stimulator may help encourage blood flow in a limb of a patient. The blood flow stimulator may include a housing configured for sealing about the limb of the patient. The housing may include a sealable volume, and the sealable volume may receive the limb of the patient. The blood flow stimulator may include a seal, and the seal may be coupled with the housing. The seal may engage with at least a portion of the limb, for instance to segregate the sealable volume from a surrounding environment of the blood flow stimulator. The blood flow stimulator may include a conduit extending through the housing. The conduit mat help provide access to the sealable volume, for instance from the surrounding environment. In some examples, an adjustable stent is utilized to enhance blood flow within vasculature of a patient. A stent operator may change a size of the stent.

Embodiments of systems and methods for monitoring use of an orthopedic device are at least disclosed. In some embodiments, the system can include an orthopedic device, a housing, and a controller. The orthopedic device can provide support to a limb of an individual. The orthopedic device can include a magnet configured to generate a magnetic field. The housing can attach to the individual, and the housing can support a magnetometer configured to generate a signal responsive to the magnetic field. The controller can determine from the signal whether the individual is using the orthopedic device to provide support to the limb and accordingly output usage indications.